Search Results - Vrethem, Magnus
- Showing 1 - 16 results of 16
-
1
-
2
-
3
Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal flu... by Vrethem, Magnus, Widhe, Mona, Ernerudh, Jan, Garpmo, Ulf, Forsberg, Pia
Published 2011Text -
4
-
5
-
6
Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-α and transforming growth factor-β(1) responses are associated with chronic neuroborreliosis by Widhe, Mona, Grusell, Mattias, Ekerfelt, Christina, Vrethem, Magnus, Forsberg, Pia, Ernerudh, Jan
Published 2002Text -
7
Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient’s T ce... by Hellqvist, Eva, Kvarnström, Maria, Söderberg, Anita, Vrethem, Magnus, Ernerudh, Jan, Rosén, Anders
Published 2010Text -
8
Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden by Wickström, Anne, Sundström, Peter, Wickström, Lucas, Dahle, Charlotte, Vrethem, Magnus, Svenningsson, Anders
Published 2015Text -
9
Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients by Mellergård, Johan, Edström, Måns, Jenmalm, Maria C., Dahle, Charlotte, Vrethem, Magnus, Ernerudh, Jan
Published 2013Text -
10
Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case–control study by Lindh, Jonas, Söderkvist, Peter, Fredrikson, Mats, Hosseininia, Shahrzad, Tondel, Martin, Persson, Bodil, Vrethem, Magnus
Published 2011Text -
11
-
12
-
13
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis by Håkansson, Irene, Tisell, Anders, Cassel, Petra, Blennow, Kaj, Zetterberg, Henrik, Lundberg, Peter, Dahle, Charlotte, Vrethem, Magnus, Ernerudh, Jan
Published 2018Text -
14
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis by Jons, Daniel, Zetterberg, Henrik, Biström, Martin, Alonso‐Magdalena, Lucia, Gunnarsson, Martin, Vrethem, Magnus, Blennow, Kaj, Nilsson, Staffan, Sundström, Peter, Andersen, Oluf
Published 2022Text -
15
Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis by Mellergård, Johan, Tisell, Anders, Dahlqvist Leinhard, Olof, Blystad, Ida, Landtblom, Anne-Marie, Blennow, Kaj, Olsson, Bob, Dahle, Charlotte, Ernerudh, Jan, Lundberg, Peter, Vrethem, Magnus
Published 2012Text -
16
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies by Luna, Gustavo, Alping, Peter, Burman, Joachim, Fink, Katharina, Fogdell-Hahn, Anna, Gunnarsson, Martin, Hillert, Jan, Langer-Gould, Annette, Lycke, Jan, Nilsson, Petra, Salzer, Jonatan, Svenningsson, Anders, Vrethem, Magnus, Olsson, Tomas, Piehl, Fredrik, Frisell, Thomas
Published 2019Text